Fig. 1
From: A novel nasal powder formulation of glucagon: toxicology studies in animal models
(a) GNP dosing device and carrying tube (b) GNP dosing device at activation
Fig. 1 | BMC Pharmacology and Toxicology
From: A novel nasal powder formulation of glucagon: toxicology studies in animal models
(a) GNP dosing device and carrying tube (b) GNP dosing device at activation